drugset / Trial / NCT00256542

Study of U101 for Bladder Pain and/or Urgency

NCT00256542

Phase 2 Completed 90 enrolled Urigen
RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether intravesical U101 (alkalinized lidocaine-heparin) treatment reduces the symptoms of pelvic pain and/or urgency of bladder origin.

Timeline

Start
2006-01
Primary completion
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Heparin Other / unclassified Other
Subject Lidocaine Other / unclassified Other